Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 67.1%

Neg 0% Neu 0% Pos 67.1%

Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $16 to $17.